| Name | Title | Contact Details |
|---|
Nutri-Mack is a Vineland, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Foundations Associates is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Brentwood, TN. To find more information about Foundations Associates, please visit www.dualdiagnosis.org
BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.
The Nimble journey began with a loved one who was sick. I found myself visiting the pharmacy multiple times per week rather than caring for my family member. This inspired me to build a different approach – an experience that centered around the patient`s needs and the provider`s workflow. My goal was that customers would LOVE the experience so much that they would tell the world about it.
Xtant Medical (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets.